Method and device for the measurement and the elimination of system changes in a device for the treatment of blood

US9400199B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9400199-B2
Application numberUS-201113878493-A
CountryUS
Kind codeB2
Filing dateOct 14, 2011
Priority dateOct 14, 2010
Publication dateJul 26, 2016
Grant dateJul 26, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a method and a device for the measurement of pressure signals in a blood treatment system, whereby system changes can be identified and can be differentiated additionally reliably between system changes in blood flow direction and in transmembrane direction in order to enable a targeted action.

First claim

Opening claim text (preview).

The invention claimed is: 1. Method for the differentiation of disturbances of the flow resistance in a blood treatment system which comprises the following steps: a) measuring at least two pressure signals selected from the group consisting of (PB 1 , PB 2 , PD 1 , PD 2 ), which are measured at least two pressure sensors, which are selected from the group consisting of [PB 1 ], [PB 2 ], [PD 1 ] and [PD 2 ], wherein [PB 1 ] represents the pressure sensor in the blood circulation before the blood inlet into the tangential flow filter TFF and PB 1 represents the pressure measured at the pressure sensor [PB 1 ], [PB 2 ] represents the pressure sensor in the blood circulation after the blood outlet from the tangential flow filter TFF and PB 2 represents the pressure measured at the pressure sensor [PB 2 ], [PD 1 ] represents the pressure sensor in the dialysate circulation before the dialysate inlet into the tangential flow filter TFF and PD 1 represents the pressure measured at the pressure sensor [PD 1 ] and [PD 2 ] represents the pressure sensor in the dialysate circulation after the dialysate outlet from the tangential flow filter TFF and PD 2 represents the pressure measured at the pressure sensor [PD 2 ]; b) calculating the quotients and/or the differences from the pressure signals measured according to step a), wherein the quotients and/or the differences are calculated from the pressure signals selected from the group consisting of (PB 1 , PB 2 ) and/or (PB 1 , PD 1 ) and/or (PB 1 , PD 2 ) and/or (PB 2 , PD 1 ) and/or (PB 2 , PD 2 ) and/or (PD 1 , PD 2 ) and/or (PB 1 , PDM) and/or (PB 2 , PDM) and/or (PD 1 , PBM) and/or (PD 2 , PBM) and/or (PDM, PBM) in a central processing unit, wherein with PBM or PDM the respective average from (PB 1 ,PB 2 ) or (PD 1 , PD 2 ) is represented; c) repeating, at least once, the steps a) and b), wherein at the same at least two pressure sensors as measured in the previous measurement and from the measured pressure signals the same quotients and/or differences are calculated; d) generating at least one time trend from the measured pressure signals selected from the group consisting of (PB 1 , PB 2 , PD 1 , PD 2 ) and/or the calculated differences, and/or quotients of the pressure signals (PB 1 , PB 2 ) and/or (PB 1 , PD 1 ) and/or (PB 1 , PD 2 ) and/or (PB 2 , PD 1 ) and/or (PB 2 , PD 2 ) and/or (PD 1 , PD 2 ) and/or (PB 1 , PDM) and/or (PB 2 , PDM) and/or (PD 1 , PBM) and/or (PD 2 , PBM) and/or (PDM, PBM); e) evaluating the at least one time trend, whether a change of the at least one time trend has occurred over a tolerance range; f) generating a pattern for the evaluation of the at least one time trend; g) assigning the pattern to a disturbance condition, such that a location and type of the disturbance condition within the blood treatment system is determined; h) displaying the disturbance condition on a display device of the central processing unit; and i) automatically eliminating, with the blood treatment system, the disturbance condition to return the flow resistance to within the tolerance range, if the system determines that the disturbance condition is of the type and location that can be automatically eliminated. 2. Method according to claim 1 , wherein the at least two pressure signals can be respectively absolute pressures, relative pressures, absolute pressure differences between two pressure measuring points, relative pressure differences between two pressure measuring points, absolute pressure amplitudes, relative pressure amplitudes, differences between the absolute pressure amplitudes at two pressure measuring points, or differences between the relative pressure amplitudes at two pressure measurement points or a combination thereof. 3. Method according to claim 1 , wherein the at least two pressure signals are determined respectively from the analysis of the frequency spectrum of the blood flow. 4. Method for the differentiation of disturbances of the flow resistance in a blood treatment system, which comprises the following steps: a) measuring, at least two different times, each of at least two pressure signals at least two pressure sensors, wherein the pressure signals are selected from the group consisting of PB 1 , PB 2 , PD 1 and PD 2 , the pressure sensors are selected from the group consisting of [PB 1 ], [PB 2 ], [PD 1 ] and [PD 2 ], [PB 1 ] represents the pressure sensor in the blood circulation before the blood inlet into the tangential flow filter TFF and PB 1 represents the pressure measured at the pressure sensor [PB 1 ], [PB 2 ] represents the pressure sensor in the blood circulation after the blood outlet from the tangential flow filter TFF and PB 2 represents the pressure measured at the pressure sensor [PB 2 ], [PD 1 ] represents the pressure sensor in the dialysate circulation before the dialysate inlet into the tangential flow filter TFF and PD 1 represents the pressure measured at the pressure sensor [PD 1 ], and [PD 2 ] represents the pressure sensor in the dialysate circulation after the dialysate outlet from the tangential flow filter TFF and PD 2 represents the pressure measured at the pressure sensor [PD 2 ]; b) calculating of at least two quotients and/or differences from the pressure signals measured time offset according to step a) at the same pressure sensor in a central processing unit, wherein the quotients calculated in such a manner according to the pressure sensor, at which the measurement has been carried out, are represented as Q[PB 1 ], Q[PB 2 ], Q[PD 1 ] and Q[PD 2 ] and the differences as Δ[PB 1 ], Δ[PB 2 ], Δ[PD 1 ] and Δ[PD 2 ]; c) calculating at least one quotient and/or at least one difference in the central processing unit from the quotients and/or differences calculated according to step b), wherein the quotients and/or the differences are selected from the group consisting of (Q[PB 1 ], Q[PB 2 ]) and/or (Q[PB 1 ], Q[PD 1 ]) and/or (Q[PB 1 ], Q[PD 2 ]) and/or (Q[PB 2 ], Q[PD 1 ]) and/or (Q[PB 2 ], Q[PD 2 ]) and/or (Q[PD 1 ], Q[PD 2 ]) and/or (Δ[PB 1 ], Δ[PB 2 ]) and/or (Δ[PB 1 ], Δ[PD 1 ]) and/or (Δ[PB 1 ], Δ[PD 2 ]) and/or (Δ[PB 2 ], Δ[PD 1 ]) and/or (Δ[PB 2 ], Δ[PD 2 ]) and/or (Δ[PD 1 ], Δ[PD 2 ]) and/or (Q[PB 1 ], (Δ[PB 1 ]) and/or (Q[PB 1 ], (Δ[PB 2 ]) and/or (Q[PB 1 ], (Δ[PD 1 ]) and/or (Q[PB 1 ], (Δ[PD 2 ]) and/or (Q[PB 2 ], (Δ[PB 1 ]) and/or (Q[PB 2 ], (Δ[PB 2 ]) and/or (Q[PB 2 ], (Δ[PD 1 ]) and/or (Q[PB 2 ], (Δ[PD 2 ]) and/or (Q[PD 1 ], (Δ[PB 1 ]) and/or (Q[PD 1 ], (Δ[PB 2 ]) and/or (Q[PD 1 ], (Δ[PD 1 ]) and/or (Q[PD 1 ], (Δ[PD 2 ]) and/or (Q[PD 2 ], (Δ[PB 1 ]) and/or (Q[PD 2 ], (Δ[PB 2 ]) and/or (Q[PD 2 ], (Δ[PD 1 ]) and/or (Q[PD 2 ], (Δ[PD 2 ]) and/or (Q[PB 1 ], Q[PBM]) and/or (Q[PB 2 ], Q[PBM]) and/or (Q[PD 1 ], Q[PBM]) and/or (Q[PD 2 ], Q[PBM]) and/or (Δ[PB 1 ], Q[PBM]) and/or (Δ[PB 2 ], Q[PBM]) and/or (Δ[PD 1 ], Q[PBM]) and/or (Δ[PD 2 ], Q[PBM]) and/or (Q[PB 1 ], Q[PDM]) and/or (Q[PB 2 ], Q[PDM]) and/or (Q[PD 1 ], Q[PDM]) and/or (Q[PD 2 ], Q[PDM]) and/or (Δ[PB 1 ], Q[PDM]) and/or (Δ[PB 2 ], Q[PDM]) and/or (Δ[PD 1 ], Q[PDM]) and/or (Δ[PD 2 ], Q[PDM]) and/or (Q[PB 1 ], Δ[PBM]) and/or (Q[PB 2 ], Δ[PBM]) and/or (Q[PD 1 ], Δ[PBM]) and/or (Q[PD 2 ], Δ[PBM]) and/or (Δ[PB 1 ], Δ[PBM]) and/or (Δ[PB 2 ], Δ[PBM]) and/or (Δ[PD 1 ], Δ[PBM]) and/or (Δ[PD 2 ], Δ[PBM]) and/or (Q[PB 1 ], Δ[PDM]) and/or (Q[PB 2 ], Δ[PDM]) and/or (Q[PD 1 ], Δ[PDM]) and/or (Q[PD 2 ], Δ[PDM]) and/or (Δ[PB 1 ], Δ[PDM]) and/or (Δ[PB 2 ], Δ[PDM]) and/or (Δ[PD 1 ], Δ[PDM]) and/or (Δ[PD 2 ], Δ[PDM]) and/or (Q[PBM], Q[PDM]) and/or (Q[PBM], Δ[PBM]) and/or (Q[PBM], Δ[PDM]) and/or (Q[PDM], Δ[PBM]) and/or (Q[PDM], Δ[PDM]) and/or (Δ[PBM], Δ[PDM]) and wherein Q[PBM] represents the average from Q[PB 1 ] and Q[PB 2 ], Q[PDM] represents the average from Q[PD 1 ] and Q[PD 2 ], Δ[PBM] represents the average from Δ[PB 1 ] and Δ[PB 2 ], Δ[PDM] represents the average

Assignees

Inventors

Classifications

  • A61M1/3639Primary

    Blood pressure control, pressure transducers specially adapted therefor · CPC title

  • automatically during use · CPC title

  • Physics · mapped topic

  • G01F1/74Primary

    Devices for measuring flow of a fluid or flow of a fluent solid material in suspension in another fluid · CPC title

  • Testing of filters for clogging · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9400199B2 cover?
The present invention relates to a method and a device for the measurement of pressure signals in a blood treatment system, whereby system changes can be identified and can be differentiated additionally reliably between system changes in blood flow direction and in transmembrane direction in order to enable a targeted action.
Who is the assignee on this patent?
Wolff Henrik, Braun Avitum Ag
What technology area does this patent fall under?
Primary CPC classification A61M1/3639. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).